0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Lung Models Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-20P20171
Home | Market Reports | Health| Medical Devices & Equipment
Global Human Lung Models Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Human Lung Models Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-20P20171
Report
October 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Lung Models Market

The global Human Lung Models market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The human lung model is a full-scale anatomical cutaway model showing the bronchi, arteries, veins, lymph nodes, bronchial passages, and tracheal bifurcation. The lung model comes with a removable patient education card and base. This model is ideal for advanced courses and medical demonstrations/education.
From a downstream perspective, School accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Human Lung Models leading manufacturers including 3B Scientific, Erler-Zimmer, HeineScientific, Axis Scientific, GPI Anatomicals, EISCO, Health Edco, etc., dominate supply; the top five capture approximately % of global revenue, with 3B Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Lung Models market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Human Lung Models Market Report

Report Metric Details
Report Name Human Lung Models Market
Segment by Type
  • Pathological Lung Model
  • Normal Lung Model
Segment by Application
  • School
  • Hospital
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 3B Scientific, Erler-Zimmer, HeineScientific, Axis Scientific, GPI Anatomicals, EISCO, Health Edco
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Human Lung Models study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Human Lung Models Market report?

Ans: The main players in the Human Lung Models Market are 3B Scientific, Erler-Zimmer, HeineScientific, Axis Scientific, GPI Anatomicals, EISCO, Health Edco

What are the Application segmentation covered in the Human Lung Models Market report?

Ans: The Applications covered in the Human Lung Models Market report are School, Hospital, Others

What are the Type segmentation covered in the Human Lung Models Market report?

Ans: The Types covered in the Human Lung Models Market report are Pathological Lung Model, Normal Lung Model

1 Study Coverage
1.1 Introduction to Human Lung Models: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Lung Models Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pathological Lung Model
1.2.3 Normal Lung Model
1.3 Market Segmentation by Application
1.3.1 Global Human Lung Models Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 School
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Lung Models Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Lung Models Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Human Lung Models Sales Estimates and Forecasts 2020-2031
2.4 Global Human Lung Models Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Human Lung Models Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Human Lung Models Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Pathological Lung Model Market Size by Manufacturers
3.5.2 Normal Lung Model Market Size by Manufacturers
3.6 Global Human Lung Models Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Lung Models Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Human Lung Models Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Lung Models Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Human Lung Models Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Human Lung Models Sales and Revenue by Type (2020-2031)
6.4 North America Human Lung Models Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Lung Models Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Human Lung Models Sales and Revenue by Type (2020-2031)
7.4 Europe Human Lung Models Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Lung Models Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Human Lung Models Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Human Lung Models Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Human Lung Models Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Human Lung Models Sales and Revenue by Type (2020-2031)
9.4 Central and South America Human Lung Models Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Lung Models Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Human Lung Models Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Human Lung Models Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Lung Models Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 3B Scientific
11.1.1 3B Scientific Corporation Information
11.1.2 3B Scientific Business Overview
11.1.3 3B Scientific Human Lung Models Product Models, Descriptions and Specifications
11.1.4 3B Scientific Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 3B Scientific Human Lung Models Sales by Product in 2024
11.1.6 3B Scientific Human Lung Models Sales by Application in 2024
11.1.7 3B Scientific Human Lung Models Sales by Geographic Area in 2024
11.1.8 3B Scientific Human Lung Models SWOT Analysis
11.1.9 3B Scientific Recent Developments
11.2 Erler-Zimmer
11.2.1 Erler-Zimmer Corporation Information
11.2.2 Erler-Zimmer Business Overview
11.2.3 Erler-Zimmer Human Lung Models Product Models, Descriptions and Specifications
11.2.4 Erler-Zimmer Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Erler-Zimmer Human Lung Models Sales by Product in 2024
11.2.6 Erler-Zimmer Human Lung Models Sales by Application in 2024
11.2.7 Erler-Zimmer Human Lung Models Sales by Geographic Area in 2024
11.2.8 Erler-Zimmer Human Lung Models SWOT Analysis
11.2.9 Erler-Zimmer Recent Developments
11.3 HeineScientific
11.3.1 HeineScientific Corporation Information
11.3.2 HeineScientific Business Overview
11.3.3 HeineScientific Human Lung Models Product Models, Descriptions and Specifications
11.3.4 HeineScientific Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 HeineScientific Human Lung Models Sales by Product in 2024
11.3.6 HeineScientific Human Lung Models Sales by Application in 2024
11.3.7 HeineScientific Human Lung Models Sales by Geographic Area in 2024
11.3.8 HeineScientific Human Lung Models SWOT Analysis
11.3.9 HeineScientific Recent Developments
11.4 Axis Scientific
11.4.1 Axis Scientific Corporation Information
11.4.2 Axis Scientific Business Overview
11.4.3 Axis Scientific Human Lung Models Product Models, Descriptions and Specifications
11.4.4 Axis Scientific Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Axis Scientific Human Lung Models Sales by Product in 2024
11.4.6 Axis Scientific Human Lung Models Sales by Application in 2024
11.4.7 Axis Scientific Human Lung Models Sales by Geographic Area in 2024
11.4.8 Axis Scientific Human Lung Models SWOT Analysis
11.4.9 Axis Scientific Recent Developments
11.5 GPI Anatomicals
11.5.1 GPI Anatomicals Corporation Information
11.5.2 GPI Anatomicals Business Overview
11.5.3 GPI Anatomicals Human Lung Models Product Models, Descriptions and Specifications
11.5.4 GPI Anatomicals Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 GPI Anatomicals Human Lung Models Sales by Product in 2024
11.5.6 GPI Anatomicals Human Lung Models Sales by Application in 2024
11.5.7 GPI Anatomicals Human Lung Models Sales by Geographic Area in 2024
11.5.8 GPI Anatomicals Human Lung Models SWOT Analysis
11.5.9 GPI Anatomicals Recent Developments
11.6 EISCO
11.6.1 EISCO Corporation Information
11.6.2 EISCO Business Overview
11.6.3 EISCO Human Lung Models Product Models, Descriptions and Specifications
11.6.4 EISCO Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 EISCO Recent Developments
11.7 Health Edco
11.7.1 Health Edco Corporation Information
11.7.2 Health Edco Business Overview
11.7.3 Health Edco Human Lung Models Product Models, Descriptions and Specifications
11.7.4 Health Edco Human Lung Models Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Health Edco Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Human Lung Models Industry Chain
12.2 Human Lung Models Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Human Lung Models Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Human Lung Models Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Lung Models Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Lung Models Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Human Lung Models Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Human Lung Models Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Human Lung Models Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Human Lung Models Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Human Lung Models Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Human Lung Models Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Human Lung Models Sales by Region (2020-2025) & (Units)
 Table 8. Global Human Lung Models Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Human Lung Models Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Human Lung Models Sales Share by Manufacturers (2020-2025)
 Table 12. Global Human Lung Models Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Human Lung Models Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Human Lung Models by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Lung Models as of 2024)
 Table 16. Global Human Lung Models Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Human Lung Models Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Human Lung Models Manufacturing Base and Headquarters
 Table 19. Global Human Lung Models Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Human Lung Models Sales by Type (2020-2025) & (Units)
 Table 23. Global Human Lung Models Sales by Type (2026-2031) & (Units)
 Table 24. Global Human Lung Models Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Human Lung Models Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Human Lung Models ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Human Lung Models Sales by Application (2020-2025) & (Units)
 Table 29. Global Human Lung Models Sales by Application (2026-2031) & (Units)
 Table 30. Human Lung Models High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Human Lung Models Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Human Lung Models Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Human Lung Models ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Human Lung Models Growth Accelerators and Market Barriers
 Table 37. North America Human Lung Models Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Human Lung Models Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Human Lung Models Growth Accelerators and Market Barriers
 Table 40. Europe Human Lung Models Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Human Lung Models Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Human Lung Models Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Human Lung Models Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Human Lung Models Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Human Lung Models Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Human Lung Models Investment Opportunities and Key Challenges
 Table 47. Central and South America Human Lung Models Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Human Lung Models Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Human Lung Models Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. 3B Scientific Corporation Information
 Table 51. 3B Scientific Description and Major Businesses
 Table 52. 3B Scientific Product Models, Descriptions and Specifications
 Table 53. 3B Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. 3B Scientific Sales Value Proportion by Product in 2024
 Table 55. 3B Scientific Sales Value Proportion by Application in 2024
 Table 56. 3B Scientific Sales Value Proportion by Geographic Area in 2024
 Table 57. 3B Scientific Human Lung Models SWOT Analysis
 Table 58. 3B Scientific Recent Developments
 Table 59. Erler-Zimmer Corporation Information
 Table 60. Erler-Zimmer Description and Major Businesses
 Table 61. Erler-Zimmer Product Models, Descriptions and Specifications
 Table 62. Erler-Zimmer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Erler-Zimmer Sales Value Proportion by Product in 2024
 Table 64. Erler-Zimmer Sales Value Proportion by Application in 2024
 Table 65. Erler-Zimmer Sales Value Proportion by Geographic Area in 2024
 Table 66. Erler-Zimmer Human Lung Models SWOT Analysis
 Table 67. Erler-Zimmer Recent Developments
 Table 68. HeineScientific Corporation Information
 Table 69. HeineScientific Description and Major Businesses
 Table 70. HeineScientific Product Models, Descriptions and Specifications
 Table 71. HeineScientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. HeineScientific Sales Value Proportion by Product in 2024
 Table 73. HeineScientific Sales Value Proportion by Application in 2024
 Table 74. HeineScientific Sales Value Proportion by Geographic Area in 2024
 Table 75. HeineScientific Human Lung Models SWOT Analysis
 Table 76. HeineScientific Recent Developments
 Table 77. Axis Scientific Corporation Information
 Table 78. Axis Scientific Description and Major Businesses
 Table 79. Axis Scientific Product Models, Descriptions and Specifications
 Table 80. Axis Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Axis Scientific Sales Value Proportion by Product in 2024
 Table 82. Axis Scientific Sales Value Proportion by Application in 2024
 Table 83. Axis Scientific Sales Value Proportion by Geographic Area in 2024
 Table 84. Axis Scientific Human Lung Models SWOT Analysis
 Table 85. Axis Scientific Recent Developments
 Table 86. GPI Anatomicals Corporation Information
 Table 87. GPI Anatomicals Description and Major Businesses
 Table 88. GPI Anatomicals Product Models, Descriptions and Specifications
 Table 89. GPI Anatomicals Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. GPI Anatomicals Sales Value Proportion by Product in 2024
 Table 91. GPI Anatomicals Sales Value Proportion by Application in 2024
 Table 92. GPI Anatomicals Sales Value Proportion by Geographic Area in 2024
 Table 93. GPI Anatomicals Human Lung Models SWOT Analysis
 Table 94. GPI Anatomicals Recent Developments
 Table 95. EISCO Corporation Information
 Table 96. EISCO Description and Major Businesses
 Table 97. EISCO Product Models, Descriptions and Specifications
 Table 98. EISCO Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. EISCO Recent Developments
 Table 100. Health Edco Corporation Information
 Table 101. Health Edco Description and Major Businesses
 Table 102. Health Edco Product Models, Descriptions and Specifications
 Table 103. Health Edco Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Health Edco Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Lung Models Product Picture
 Figure 2. Global Human Lung Models Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Pathological Lung Model Product Picture
 Figure 4. Normal Lung Model Product Picture
 Figure 5. Global Human Lung Models Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. School
 Figure 7. Hospital
 Figure 8. Others
 Figure 9. Human Lung Models Report Years Considered
 Figure 10. Global Human Lung Models Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Human Lung Models Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Human Lung Models Revenue Market Share by Region (2020-2031)
 Figure 14. Global Human Lung Models Sales (2020-2031) & (Units)
 Figure 15. Global Human Lung Models Sales (CAGR) by Region (2020-2031) (Units)
 Figure 16. Global Human Lung Models Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Human Lung Models Sales Volume Market Share in 2024
 Figure 18. Global Human Lung Models Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Pathological Lung Model Revenue Market Share by Manufacturer in 2024
 Figure 21. Normal Lung Model Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Human Lung Models Sales Market Share by Type (2020-2031)
 Figure 23. Global Human Lung Models Revenue Market Share by Type (2020-2031)
 Figure 24. Global Human Lung Models Sales Market Share by Application (2020-2031)
 Figure 25. Global Human Lung Models Revenue Market Share by Application (2020-2031)
 Figure 26. North America Human Lung Models Sales YoY (2020-2031) & (Units)
 Figure 27. North America Human Lung Models Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Human Lung Models Sales Revenue (US$ Million) in 2024
 Figure 29. North America Human Lung Models Sales Volume (Units) by Type (2020- 2031)
 Figure 30. North America Human Lung Models Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Human Lung Models Sales Volume (Units) by Application (2020-2031)
 Figure 32. North America Human Lung Models Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Human Lung Models Sales YoY (2020-2031) & (Units)
 Figure 37. Europe Human Lung Models Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Human Lung Models Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Human Lung Models Sales Volume (Units) by Type (2020-2031)
 Figure 40. Europe Human Lung Models Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Human Lung Models Sales Volume (Units) by Application (2020-2031)
 Figure 42. Europe Human Lung Models Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 44. France Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Human Lung Models Sales YoY (2020-2031) & (Units)
 Figure 49. Asia-Pacific Human Lung Models Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Human Lung Models Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Human Lung Models Sales Volume (Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Human Lung Models Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Human Lung Models Sales Volume (Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Human Lung Models Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 59. India Human Lung Models Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Human Lung Models Sales YoY (2020-2031) & (Units)
 Figure 61. Central and South America Human Lung Models Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Human Lung Models Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Human Lung Models Sales Volume (Units) by Type (2021-2031)
 Figure 64. Central and South America Human Lung Models Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Human Lung Models Sales Volume (Units) by Application (2020-2031)
 Figure 66. Central and South America Human Lung Models Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Human Lung Models Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Human Lung Models Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Human Lung Models Sales YoY (2020-2031) & (Units)
 Figure 70. Middle East and Africa Human Lung Models Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Human Lung Models Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Human Lung Models Sales Volume (Units) by Type (2021-2031)
 Figure 73. South America Human Lung Models Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Human Lung Models Sales Volume (Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Human Lung Models Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Human Lung Models Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Human Lung Models Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Human Lung Models Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Human Lung Models Revenue (2020-2025) & (US$ Million)
 Figure 80. Human Lung Models Industry Chain Mapping
 Figure 81. Regional Human Lung Models Manufacturing Base Distribution (%)
 Figure 82. Global Human Lung Models Production Market Share by Region (2020-2031)
 Figure 83. Human Lung Models Production Process
 Figure 84. Regional Human Lung Models Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart